Bio-medical Carbon Technology Co., Ltd.
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
1 terminated/withdrawn out of 5 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
A Comparative Efficacy and Safety Study Between Two Silver Containing Dressings In Post-Op Wound Healing
Role: lead
To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Superficial Dermal Burn
Role: lead
To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Deep Dermal Burn
Role: lead
The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing
Role: lead
Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
Role: collaborator
All 5 trials loaded